4th Quarter - Report

FORBES-TATE for VIR BIOTECHNOLOGY, INC.

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Healthcare initiatives related to novel antibody technology platform; Issues related to COVID funding.

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Government Issues GOV

Healthcare initiatives related to novel antibody technology platform.

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Issues related to COVID funding.

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Taxation/Internal Revenue Code TAX

Issues related to research and development tax credit.

LobbyistCovered position, as disclosed
CYNTHIA BROWN —
BARRETT THORNHILL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.